The National Institute of General Medical Sciences (NIGMS) awards Lectenz® Bio a second SBIR Phase I to apply the GlycoSenseTM technology to monitoring glycoenzyme engineering reactions.
Call Us Now: +1 (706) 549-4484
The National Institute of General Medical Sciences (NIGMS) awards Lectenz® Bio a second SBIR Phase I to apply the GlycoSenseTM technology to monitoring glycoenzyme engineering reactions.